MedPath

Efficacy of transcranial direct current stimulation(tDCS) on schizophrenia

Not Applicable
Conditions
Schizophrenia.
Schizophrenia, schizotypal and delusional disorders
F20-F29
Registration Number
IRCT20200203046366N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

People diagnosed with schizophrenia on thebasis of DSM5
Patients receiving fixed antipsychotic treatment regimen for at least 4 weeks

Exclusion Criteria

1-substance dependency
comorbid psychiatric disorder(including suicidal individuals)
neurologic diseases such as epilepcy,CVA or cerebral vessels disease
physical disease such as malignancy,infections and heart failure, pragnancy, the existence of a metal implant in the body and skin disease involving scalp

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Positive and negative symptoms of schizophrenia. Timepoint: Pre-test, Post-test and follow up (one month after post-test). Method of measurement: Positive and Negative Syndrome Scale.;Negative Symptoms. Timepoint: Pre-test, Post-test and follow up (one month after post-test). Method of measurement: Scale for the Assessment of Negative Symptoms.;Depression. Timepoint: Pre-test, Post-test and follow up (one month after post-test). Method of measurement: Calgary Depression Scale for Schizophrenia.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath